Physician
Psychiatry
Dr. Kirk D. Denicoff, MD
|
|
Give Review
Dr. Kirk D. Denicoff practices Psychiatry. He studied medicine at Mount Sinai School of Medicine. He over the years received 1 awards: "Top MD". Dr. Kirk D. Denicoff is a published doctor and has 72 publications published. The lastest was: 'A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.' Kirk D. Denicoff accepts all Medicare patients.
Publications
- Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of Bipolar depression and rapid cycling Bipolar disorder.
- Risk of switch in mood polarity to hypomania or mania in patients with Bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropio...
- Comparison of rapid-cycling and non-rapid-cycling Bipolar disorder based on prospective mood ratings in 539 outpatients.
- An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of Bipolar depression.
- Pramipexole for Bipolar II depression: a placebo-controlled proof of concept study.
- Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood Disorders: role of the glutamatergic system.
- Psychosis in Bipolar disorder: phenomenology and impact on morbidity and course of illness.
- Morbidity in 258 Bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.
- Factors associated with suicide attempts in 648 patients with Bipolar disorder in the Stanley Foundation Bipolar Network.
- High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in Bipolar disorder.
- Correlates of overweight and obesity in 644 patients with Bipolar disorder.
- High rate of autoimmune thyroiditis in Bipolar disorder: lack of association with lithium exposure.
- Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of Bipolar disorder.
- Alternate-day corticosteroid treatment, mood and plasma HVA in patients with systemic lupus erythematosus.
- Chronic patient has numerous changes in drugs, therapists; makes only limited gains.
- T2 hyperintensities in Bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis.
- Olanzapine in treatment-resistant Bipolar disorder.
- Clozapine in Bipolar disorder: treatment implications for other atypical antipsychotics.
- Gabapentin in the acute treatment of refractory Bipolar disorder.
- Rational polypharmacy in the Bipolar affective disorders.
- High levels of Gs alpha in platelets of euthymic patients with Bipolar affective disorder.
- The place of anticonvulsant therapy in Bipolar illness.
- The emerging role of cytochrome P450 3A in psychopharmacology.
- New developments in the use of anticonvulsants as mood stabilizers.
- Treatment of rapid cycling Bipolar illness.
- Antiepileptic drugs in affective illness. Clinical and theoretical implications.
- Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in Bipolar disorder.
- Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
- Impact of antidepressant discontinuation after acute Bipolar depression remission on rates of depressive relapse at 1-year follow-up.
- The poor prognosis of childhood-onset Bipolar disorder.
- Emerging trends in the treatment of rapid cycling Bipolar disorder: a selected review.
- Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with Bipolar disorder.
- Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of Bipolar illness.
- MRI-based measurements of temporal lobe and ventricular structures in patients with Bipolar I and Bipolar II disorders.
- Neuroleptic exposure in Bipolar outpatients in a research setting.
- Open-label adjunctive topiramate in the treatment of Bipolar disorders.
- Special issues in trial design and use of placebo in Bipolar illness.
- The increasing use of polypharmacotherapy for refractory mood Disorders: 22 years of study.
- A preliminary study of the relation of neuropsychological performance to neuroanatomic structures in Bipolar disorder.
- Relationship between prior course of illness and neuropsychological functioning in patients with Bipolar disorder.
- Association between lower serum free T4 and greater mood instability and depression in lithium-maintained Bipolar patients.
- Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in Bipolar disorder.
- Lamotrigine for the treatment of Bipolar disorder: a clinical case series.
- A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.
- The efficacy and use of anticonvulsants in mood Disorders.
- Beyond lithium in the treatment of Bipolar illness.
- Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in Bipolar disorder.
- Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p).
- Psychosensory symptoms in Bipolar disorder.
- Algorithms for Bipolar mania.
- Alternative approaches to refractory depression in Bipolar illness.
- Valproate prophylaxis in a prospective clinical trial of refractory Bipolar disorder.
- Depression and carcinoma of the pancreas.
- The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.
- Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus.
- The neuroendocrine effects of interleukin-2 treatment.
- Glucose tolerance testing in women with premenstrual syndrome.
- Suicidal ideation in Darier's disease.
- Neuropsychiatric manifestations of altered thyroid state.
- Models for research in consultation psychiatry.
- Relationship between prior course of illness and neuroanatomic structures in Bipolar disorder: a preliminary study.
- The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments.
- The Stanley Foundation Bipolar Network. I. Rationale and methods.
- Efficacy of carbamazepine compared with other agents: a clinical practice survey.
- Rate of switch in Bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
- The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.
- The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.
- Tiagabine in treatment refractory Bipolar disorder: a clinical case series.
- Mood switch in Bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
- A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with Bipolar disord...
- Emerging experimental therapeutics for Bipolar disorder: clues from the molecular pathophysiology.
Schools
The Warren Alpert Medical School Of Brown University
Mt Sinai Hospital
Nimh
Brandeis U
Procedures Preformed
- Medication Management
- Psychiatric Evaluation
- Psychiatric Medication Therapy
Conditions Treated
- Bipolar Disorder
- Generalized Anxiety Disorder
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Top MD
Education
-
National Institutes of Health Clinical Center -
Mount Sinai School of Medicine -
Warren Alpert Medical School of Brown University
Drug Facts
| NPI NUMBER | 1447478995 | |
| NPPES Provider LastName | DENICOFF | |
| NPPES Provider FirstName | KIRK | |
| NPPES Provider ZIPCode | 208141516 | |
| NPPES Provider State | MD | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 702.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447478995 |
| Last Name Of The Provider | DENICOFF |
| First Name Of The Provider | KIRK |
| View All |
Similar Doctors
|
|
Dr. Anna Y. Choe, DO |
|
|
Dr. Ryan M. Chiarella, DO |
|
|
Dr. Hao Y. Tan, MD |
|
|
Dr. Juan M. Saavedra, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Andrew M. Speer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Ryan, MD |
|
|
Dr. Albert A. Zachik, MD
This Doctor is OpenDoctor Recommended.
|